Heterologous prion-forming proteins interact to cross-seed aggregation in Saccharomyces cerevisiae

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Keefer, Kathryn M ^a   Stein, Kevin C ^b   True, Heather L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN AGGREGATE; PROTEIN BINDING; SACCHAROMYCES CEREVISIAE PROTEIN;

BIOLOGICAL MODEL; CHEMISTRY; METABOLISM; POLYMERIZATION; PRION; SACCHAROMYCES CEREVISIAE;

MODELS, BIOLOGICAL; POLYMERIZATION; PRIONS; PROTEIN AGGREGATES; PROTEIN BINDING; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 85025667177     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-05829-5     Document Type: Article

References (52)

1. Morales, R., Moreno-Gonzalez, I. & Soto, C. Cross-Seeding of Misfolded Proteins: Implications for Etiology and Pathogenesis of Protein Misfolding Diseases. PLoS Pathog. 9 (2013).
2. Götz, J., Chen, F., van Dorpe, J. & Nitsch, R. M. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293, 1491-1495 (2001).
3. Ono, K., Takahashi, R., Ikeda, T. & Yamada, M. Cross-seeding effects of amyloid ?-protein and ?-synuclein. J. Neurochem 122, 883-890 (2012).
4. Guo, J. L. et al. Distinct ?-synuclein strains differentially promote tau inclusions in neurons. Cell 154, 103-117 (2013).
5. Moreno-Gonzalez, I. et al. Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding. Mol. Psychiatry, doi:10. 1038/mp. 2016. 230 (2017).
6. Derkatch, I. L., Chernoff, Y. O., Kushnirov, V. V., Inge-Vechtomov, S. G. & Liebman, S. W. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 144, 1375-1386 (1996).
7. Bradley, M. E., Edskes, H. K., Hong, J. Y., Wickner, R. B. & Liebman, S. W. Interactions among prions and prion 'strains' in yeast. Proc. Natl. Acad. Sci. USA 99, 16392-16399 (2002).
8. Huang, V. J., Stein, K. C. & True, H. L. Spontaneous variants of the [RNQ+] prion in yeast demonstrate the extensive conformational diversity possible with prion proteins. PloS One 8, e79582 (2013).
9. Stein, K. C. & True, H. L. Prion Strains and Amyloid Polymorphism Influence Phenotypic Variation. PLOS Pathog. 10, e1004328 (2014).
10. Derkatch, I. L. et al. Dependence and independence of [PSI+] and [PIN+]: A two-prion system in yeast? EMBO J 19, 1942-1952 (2000).
11. Du, Z. & Li, L. Investigating the Interactions of Yeast Prions: [SWI+], [PSI+], and [PIN+]. Genetics 197, 685-700 (2014).
12. Arslan, F., Hong, J. Y., Kanneganti, V., Park, S.-K. & Liebman, S. W. Heterologous Aggregates Promote De Novo Prion Appearance via More than One Mechanism. PLOS Genet. 11, e1004814 (2015).
13. Liebman, S. W. & Chernoff, Y. O. Prions in Yeast. Genetics 191, 1041-1072 (2012).
14. Derkatch, I. L., Bradley, M. E., Zhou, P., Chernoff, Y. O. & Liebman, S. W. Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae. Genetics 147, 507-519 (1997).
15. Derkatch, I. L. & Liebman, S. W. Prion-Prion Interactions. Prion 1, 161-169 (2007).
16. Derkatch, I. L., Bradley, M. E., Hong, J. Y. & Liebman, S. W. Prions affect the appearance of other prions: the story of [PIN(+)]. Cell 106, 171-182 (2001).
17. Osherovich, L. Z., Cox, B. S., Tuite, M. F. & Weissman, J. S. Dissection and Design of Yeast Prions. PLOS Biol. 2, e86 (2004).
18. Osherovich, L. Z. & Weissman, J. S. The Utility of Prions. Dev. Cell 2, 143-151 (2002).
19. Derkatch, I. L. et al. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proc. Natl. Acad. Sci. USA 101, 12934-12939 (2004).
20. Choe, Y.-J., Ryu, Y., Kim, H.-J. & Seok, Y.-J. Increased [PSI+] Appearance by Fusion of Rnq1 with the Prion Domain of Sup35 in Saccharomyces cerevisiae. Eukaryot. Cell 8, 968-976 (2009).
21. Vitrenko, Y. A., Gracheva, E. O., Richmond, J. E. & Liebman, S. W. Visualization of Aggregation of the Rnq1 Prion Domain and Cross-seeding Interactions with Sup35NM. J. Biol. Chem. 282, 1779-1787 (2007).
22. Sharma, J. & Liebman, S. W. Exploring the basis of [PIN+] variant differences in [PSI+] induction. J. Mol. Biol. 425, 3046-3059 (2013).
23. Duennwald, M. L., Echeverria, A. & Shorter, J. Small Heat Shock Proteins Potentiate Amyloid Dissolution by Protein Disaggregases from Yeast and Humans. PLoS Biol. 10, e1001346 (2012).
24. Guthrie, C. & Fink, G. Guide to Yeast Genetics and Molecular Biology (Academic Press, Inc, 1991).
25. Glover, J. R. et al. Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell 89, 811-819 (1997).
26. Kalastavadi, T. & True, H. L. Analysis of the [RNQ+] Prion Reveals Stability of Amyloid Fibers as the Key Determinant of Yeast Prion Variant Propagation. J. Biol. Chem. 285, 20748-20755 (2010).
27. Westergard, L. & True, H. L. Extracellular environment modulates the formation and propagation of particular amyloid structures. Mol. Microbiol. 92, 698-715 (2014).
28. Westergard, L. & True, H. L. Wild yeast harbor a variety of distinct amyloid structures with strong prion-inducing capabilities. Mol. Microbiol. 92, 183-193 (2014).
29. Keefer, K. M. & True, H. L. Prion-Associated Toxicity is Rescued by Elimination of Cotranslational Chaperones. PLOS Genet. 12, e1006431 (2016).
30. Tank, E. M. H., Harris, D. A., Desai, A. A. & True, H. L. Prion Protein Repeat Expansion Results in Increased Aggregation and Reveals Phenotypic Variability. Mol. Cell. Biol. 27, 5445-5455 (2007).
31. Kalastavadi, T. & True, H. L. Prion protein insertional mutations increase aggregation propensity but not fiber stability. BMC Biochem. 9, 7 (2008).
32. Lindgren, M., Sörgjerd, K. & Hammarström, P. Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy. Biophys. J. 88, 4200-4212 (2005).
33. Kurahashi, H. et al. [PSI(+)] aggregate enlargement in rnq1 nonprion domain mutants, leading to a loss of prion in yeast. Genes Cells Devoted Mol. Cell. Mech 16, 576-589 (2011).
34. Shibata, S., Kurahashi, H. & Nakamura, Y. Localization of prion-destabilizing mutations in the N-terminal non-prion domain of Rnq1 in Saccharomyces cerevisiae. Prion 3, 250-258 (2009).
35. Stein, K. C. & True, H. L. Extensive Diversity of Prion Strains Is Defined by Differential Chaperone Interactions and Distinct Amyloidogenic Regions. PLOS Genet. 10, e1004337 (2014).
36. Kadnar, M. L., Articov, G. & Derkatch, I. L. Distinct Type of Transmission Barrier Revealed by Study of Multiple Prion Determinants of Rnq1. PLOS Genet. 6, e1000824 (2010).
37. Bardill, J. P. & True, H. L. Heterologous Prion Interactions Are Altered by Mutations in the Prion Protein Rnq1p. J. Mol. Biol. 388, 583-596 (2009).
38. Inge-Vechtomov, S. G., Tikhodeev, O. N. & Karpova, T. S. [Selective systems for obtaining recessive ribosomal suppressors in saccharomycete yeasts]. Genetika 24, 1159-1165 (1988).
39. Ferreira, P. C., Ness, F., Edwards, S. R., Cox, B. S. & Tuite, M. F. The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol. Microbiol. 40, 1357-1369 (2001).
40. Shkundina, I. S., Kushnirov, V. V., Tuite, M. F. & Ter-Avanesyan, M. D. The Role of the N-Terminal Oligopeptide Repeats of the Yeast Sup35 Prion Protein in Propagation and Transmission of Prion Variants. Genetics 172, 827-835 (2006).
41. Kushnirov, V. V., Alexandrov, I. M., Mitkevich, O. V., Shkundina, I. S. & Ter-Avanesyan, M. D. Purification and analysis of prion and amyloid aggregates. Methods San Diego Calif 39, 50-55 (2006).
42. Krishnan, R. & Lindquist, S. L. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 435, 765-772 (2005).
43. Raychaudhuri, S., Dey, S., Bhattacharyya, N. P. & Mukhopadhyay, D. The Role of Intrinsically Unstructured Proteins in Neurodegenerative Diseases. PLOS ONE 4, e5566 (2009).
44. Uversky, V. N. et al. Pathological Unfoldomics of Uncontrolled Chaos: Intrinsically Disordered Proteins and Human Diseases. Chem. Rev. 114, 6844-6879 (2014).
45. Allen, K. D. et al. Hsp70 chaperones as modulators of prion life cycle: novel effects of Ssa and Ssb on the Saccharomyces cerevisiae prion [PSI+]. Genetics 169, 1227-1242 (2005).
46. Masison, D. C., Kirkland, P. A. & Sharma, D. Influence of Hsp70s and their regulators on yeast prion propagation. Prion 3, 65-73 (2009).
47. Stein, K. C. & True, H. L. Structural variants of yeast prions show conformer-specific requirements for chaperone activity. Mol. Microbiol. 93, 1156-1171 (2014).
48. Tanaka, M., Collins, S. R., Toyama, B. H. & Weissman, J. S. The physical basis of how prion conformations determine strain phenotypes. Nature 442, 585-589 (2006).
49. Toyama, B. H., Kelly, M. J. S., Gross, J. D. & Weissman, J. S. The structural basis of yeast prion strain variants. Nature 449, 233-237 (2007).
50. Knowles, T. P. J., Vendruscolo, M. & Dobson, C. M. The amyloid state and its association with protein misfolding diseases. Nat. Rev. Mol. Cell Biol. 15, 384-396 (2014).
51. Stefanacci, R. G. The costs of Alzheimer's disease and the value of effective therapies. Am. J. Manag. Care 17(Suppl 13), S356-362 (2011).
52. Akter, K. et al. Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? Br. J. Clin. Pharmacol 71, 365-376 (2011).